Long-term correction of hemophilia A via integration of a functionally enhanced FVIII gene into the AAVS1 locus by nickase in patient-derived iPSCs
Abstract Hemophilia A (HA) is caused by mutations in coagulation factor VIII (FVIII). Genome editing in conjunction with patient-derived induced pluripotent stem cells (iPSCs) is a promising cell therapy strategy, as it replaces dysfunctional proteins resulting from genetic mutations with normal pro...
Saved in:
Main Authors: | Do-Hun Kim, Sang-Hwi Choi, Jin Jea Sung, Sieun Kim, Hanui Yi, Sanghyun Park, Chan Wook Park, Young Woo Oh, Jungil Lee, Dae-Sung Kim, Jong-Hoon Kim, Chul-Yong Park, Dong-Wook Kim |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2025-01-01
|
Series: | Experimental and Molecular Medicine |
Online Access: | https://doi.org/10.1038/s12276-024-01375-z |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Acquired Hemophilia A (FVIII Deficiency) Associated with Papillary Thyroid Cancer: Treatment with Recombinant Porcine FVIII
by: S. Nguyen, et al.
Published: (2019-01-01) -
Nanosensor-based imaging of realtime dopamine release in neurons derived from iPSCs of patients with Parkinson's disease
by: Nayeon Lee, et al.
Published: (2025-04-01) -
Flow Cytometry Evaluation of Blood-Cell-Bound Surface FVIII in Hemophilia A and Thrombosis
by: Anjud Al-Mohannadi, et al.
Published: (2025-01-01) -
Editorial: Induced pluripotent stem cells (iPSCs) for skeletal muscle diseases
by: Hidetoshi Sakurai, et al.
Published: (2025-01-01) -
iPSCs: A Minireview from Bench to Bed, including Organoids and the CRISPR System
by: Andrés Javier Orqueda, et al.
Published: (2016-01-01)